Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK.

Georgina NakaferoMatthew J GraingeHywel C WilliamsTim CardMaarten W TaalGuruprasad Padur AithalChristopher P FoxChristian D MallenDanielle A van der WindtMatthew D StevensonRichard D RileyAbhishek Abhishek

Published in: BMJ (Clinical research ed.) (2023)

A prognostic model was developed and validated that uses information collected during routine clinical care and may be used to risk stratify the frequency of monitoring blood test during long term methotrexate treatment.

Keyphrases

primary care
high dose
oxidative stress
palliative care
clinical practice
big data
pain management
affordable care act
machine learning